Publication | Open Access
The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health System
25
Citations
9
References
2021
Year
Screening and diagnosis rates declined after the COVID-19 pandemic. Prioritizing screening for patients at greatest risk for HCC may reduce delays in diagnosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1